Subgroup efficacy analysis: Orthostatic hypotension questionnaire composite score in patients with neurogenic orthostatic hypotension treated with droxidopa

被引：0
|
作者：
Wenning, G.
Low, P.
Szakacs, C.
Kaufmann, H.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1305
引用
下载
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [21] Cognitive and Behavioral Side Effects in Patients Treated with Droxidopa for Neurogenic Orthostatic Hypotension
    McDonell, Katherine
    Shibao, Cyndya
    Biaggioni, Italo
    Robertson, David
    Claassen, Daniel
    NEUROLOGY, 2016, 86
  • [22] Responder analyses of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Rowse, G. J.
    Hewitt, L. A.
    Shields, A.
    Freeman, R.
    Kaufmann, H.
    MOVEMENT DISORDERS, 2015, 30 : S116 - S117
  • [23] Responder Analyses of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension
    Rowse, Gerald
    Hewitt, Lawrence
    Shields, Alan
    Freeman, Roy
    Kaufmann, Horacio
    NEUROLOGY, 2016, 86
  • [24] Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension
    White, William B.
    Hauser, Robert A.
    Rowse, Gerald J.
    Ziemann, Adam
    Hewitt, L. Arthur
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (07): : 1111 - 1115
  • [25] Integrated Efficacy and Safety Analyses of Droxidopa for Symptomatic Neurogenic Orthostatic Hypotension
    Hauser, R. A.
    Szakacs, C. B.
    Hewitt, L.
    Kaufmann, H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S33 - S33
  • [26] INTEGRATED EFFICACY AND SAFETY ANALYSES OF DROXIDOPA FOR SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION
    Hauser, R. A.
    Hewitt, L. A.
    Lee, D.
    Ziemann, A.
    Kaufmann, H.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 156 - 156
  • [27] Unit Droxidopa - a Treatment Option for neurogenic orthostatic Hypotension?
    Schuberth, Madeleine
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2014, 82 (12) : 676 - 676
  • [28] Effect of Age on the Efficacy and Safety of Droxidopa for Symptomatic Neurogenic Orthostatic Hypotension
    Peng, Guangbin
    Rowse, Gerald
    Couchenour, Rachel
    Beier, Manju
    NEUROLOGY, 2016, 86
  • [29] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, Clement
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Vo, Pamela
    Hauser, Robert A.
    BMC NEUROLOGY, 2016, 16
  • [30] Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases
    Perez-Lloret, Santiago
    Quarracino, Cecilia
    Otero-Losada, Matilde
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 635 - 645
12345